EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Drug Monitoring of Clobazam, Perampanel, and Lacosamide Using a UPLC‐MS/MS Method: Analysis of 5‐Year Experience in a Large Cohort of Pediatric Epilepsy Patients From China

Ting Zhao iD, Hui-Lan Zhang, Jing Yu, Jie Feng, Hong-Jian Li, Yan Sun, Lu-Hai Yu

Biomedical Chromatography · 2026

DOI: 10.1002/bmc.70403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Ting Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Xinjiang, China. Hauptthemen laut MEDLINE: Lacosamide, Tandem Mass Spectrometry, Pyridones, Epilepsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Natural Science Foundation of Xinjiang Uygur Autonomous Region, 2024 Pharmaceutical Science and Technology Research Project of Chinese Medicine Education Association, Youth Support Project of Tianshan Talents Training Program of Xinjiang Uygur Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to develop an ultra high‐performance liquid chromatography–mass spectrometry (UPLC‐MS/MS) method to quantify clobazam, perampanel, and lacosamide plasma concentrations in pediatric epilepsy patients. Elution was performed using a gradient elution program, with a mobile phase composed of 0.01% formic acid in water and 0.01% formic acid in acetonitrile. The flow rate was 0.6 mL/min. The injector temperature was 10°C. The injection volume was 4 μL. Linearity, sensitivity, precision, accuracy, specificity, carryover, and extraction recovery were evaluated. Therapeutic drug monitoring data of 1132 samples were analyzed. The method was linear within 10–600 ng/mL, 100–2000 ng/mL, and 1.0–30.0 μg/mL for clobazam, perampanel, and lacosamide, respectively ( r ≥ 0.998). The results indicated that the within‐run and between‐run precision coefficient of variation (CV %) did not exceed 15.0%, and that the accuracy (bias) ranged from −8.3% to 13.6%. Recovery ranged from 90.9% to 108.1%. All plasma samples could be maintained for up to 3 h at ambient temperature, 24 h at 4°C, 30 days at −30°C, and after successive freeze–thaw cycles in the absence of significant degradation. We successfully developed a simple and rapid LC‐MS/MS method for the simultaneous measurement of three new generation ASMs, and successfully applied it to clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LacosamideTandem Mass SpectrometryPyridonesEpilepsyDrug MonitoringClobazamAcetamidesAnticonvulsantsLiquid Chromatography-Mass SpectrometryHumansNitrilesReproducibility of ResultsChromatography, High Pressure LiquidChildLinear ModelsChinaChild, PreschoolMaleLimit of DetectionFemaleSensitivity and SpecificityBenzodiazepines

Stichwörter der Autor:innen

UPLC‐MS/MSclobazamlacosamideperampanelplasma concentration

Substanzen

LacosamideperampanelNitrilesPyridonesClobazamAcetamidesAnticonvulsantsBenzodiazepines

Autor:innen und Institutionen

  • Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Xinjiang, China.
  • Department of Pharmacy, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang, China.
  • Institute of Clinical Pharmacy of Xinjiang Uygur Autonomous Region, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang, China.
  • Department of Neurology, Xinjiang Hospital of Beijing Children's Hospital, Children's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang, China.

ORCID-Profile: Ting Zhao

Förderung

  • Natural Science Foundation of Xinjiang Uygur Autonomous Region
  • 2024 Pharmaceutical Science and Technology Research Project of Chinese Medicine Education Association
  • Youth Support Project of Tianshan Talents Training Program of Xinjiang Uygur Autonomous Region
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, T., Zhang, H. L., Yu, J., Feng, J., Li, H. J., Sun, Y., & Yu, L. H. (2026). Therapeutic Drug Monitoring of Clobazam, Perampanel, and Lacosamide Using a UPLC‐MS/MS Method: Analysis of 5‐Year Experience in a Large Cohort of Pediatric Epilepsy Patients From China. Biomedical Chromatography. https://doi.org/10.1002/bmc.70403

Vancouver

Zhao T, Zhang HL, Yu J, Feng J, Li HJ, Sun Y, et al. Therapeutic Drug Monitoring of Clobazam, Perampanel, and Lacosamide Using a UPLC‐MS/MS Method: Analysis of 5‐Year Experience in a Large Cohort of Pediatric Epilepsy Patients From China. Biomedical Chromatography. 2026. doi:10.1002/bmc.70403

BibTeX
@article{Zhao2026,
  author = {Zhao, Ting and Zhang, Hui-Lan and Yu, Jing and Feng, Jie and Li, Hong-Jian and Sun, Yan and Yu, Lu-Hai},
  title = {Therapeutic Drug Monitoring of Clobazam, Perampanel, and Lacosamide Using a UPLC‐MS/MS Method: Analysis of 5‐Year Experience in a Large Cohort of Pediatric Epilepsy Patients From China},
  journal = {Biomedical Chromatography},
  year = {2026},
  doi = {10.1002/bmc.70403}
}
Kostenlos starten →